title: Radiographic regression of vestibular schwannomas induced by bevacizumab treatment: sustain under continuous drug application and rebound after drug discontinuation.
authors.affiliation: Department of Maxillofacial Surgery. Electronic address: v.mautner@uke.de.
authors.forename: V-F
authors.initials: VF
authors.lastname: Mautner
authors.affiliation: Department of Maxillofacial Surgery.
authors.forename: R
authors.initials: R
authors.lastname: Nguyen
authors.affiliation: Department of Ears, Nose and Throat.
authors.forename: R
authors.initials: R
authors.lastname: Knecht
authors.affiliation: Department of Oncology/Hematology, Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
authors.forename: C
authors.initials: C
authors.lastname: Bokemeyer
mesh_terms: D000328:Adult; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D009464:Neuroma, Acoustic / Q000000981:diagnostic imaging* / Q000188:drug therapy*; D011859:Radiography; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors / Q000276:immunology; D055815:Young Adult
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab